Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Get Free Report) President Michael Halstead sold 22,869 shares of the company’s stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $89.12, for a total transaction of $2,038,085.28. The transaction was disclosed in a filing with the SEC, which can be accessed […]